Survey
Quarterly Survey: Breast Implants February 2023
Ticker(s): JNJ, SIEN, ABBVThis survey includes 20 Plastic Surgeons.
How many breast implant procedures do you perform on average each month?
How
would you best describe your practice?
- Community
- Academic
- Other
How many patient breast implant procedures used
the following manufacturers in the last 90 days:
- Allergan:
- Mentor:
- Sientra:
- Other:
How many patient breast implant procedures do you
expect to use each of the following in the next 90 days:
- Allergan:
- Mentor:
- Sientra:
- Other:
What is the percentage breakdown of breast
implant brands you use today? Please specify between 0-100 for each (sum to
100%)
- Allergan:
- Mentor:
- Sientra:
- Other:
How do you expect your usage to change moving forward?
Which
breast implant manufacturer do you prefer? Select one.
- Allergan:
- Mentor:
- Sientra:
- Other:
Please elaborate on your preference.
How would your rate Allergen on the following
(where 1 is low and 5 is high)?
- Safety
- Efficacy
- Payor Access
How would your rate Mentor on the following
(where 1 is low and 5 is high)?
- Safety
- Efficacy
- Payor Access
How would your rate Sientra on the following
(where 1 is low and 5 is high)?
- Safety
- Efficacy
- Payor Access
What features being added to future generation of breast implants would have you consider switching brands/manufacturers or significantly shifting share?
What changes, if any, have you noticed with payor reimbursement and insurance for breast implants?
What is the most exciting new treatment/device/area of development in your specialty?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
